CannaPharmaRx, Inc. (CPMD)
0.0055
0.00 (0.00%)
USD |
OTCM |
Jan 15, 16:00
CannaPharmaRx EPS Diluted (Quarterly): -0.0022 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.478M |
| Revenue (Quarterly) | 0.6566M |
| Total Expenses (Quarterly) | 2.134M |
| Enterprise Value | 24.29M |
| Gross Profit Margin (Quarterly) | -67.01% |
| Profit Margin (Quarterly) | -225.1% |
| Earnings Yield | -201.8% |
| Normalized Earnings Yield | -218.18 |